drugset

drugset / Trial / NCT05997927

Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

NCT05997927 ↗

Phase 2 Completed 149 enrolled Jiangsu vcare pharmaceutical technology co., LTD

RandomizedSequentialDouble-blindTreatment

Summary

This clinical trial is a multicenter, randomized, double-blind, controlled phase II clinical study.

Timeline

Start: 2023-07-20
Primary completion: 2024-07-09
Completion: 2024-07-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	VC005 tablets	Unknown	—	—

Indications